Bluechiip Sells Developer Kits to Two New Clients
Sydney, June 7, 2016 AEST (ABN Newswire) - Bluechiip Limited (
ASX:BCT) is pleased to announce it has received orders from two new firms to trial its sample-tracking technology.
A US-based cryogenics consumables manufacturer and a local research institution have each purchased developer kits to further evaluate the benefits of Bluechiip.
Andrew McLellan, Bluechiip's Managing Director and Chief Executive Officer, said, "Momentum is building as we continue to expand our partnering pipeline and sell more product. Sales of developer kits is an important step in the sales process as potential partners are able to further evaluate and validate the incorporation of Bluechiip technology into their products and processes."
About Bluechiip Limited
Bluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.
Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.
Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.
Bluechiip: Delivering confidence in every sample.
| ||
|
